Kamiren (Doxazosin)

Doxazosin acts on the alpha‑1 adrenergic receptor pathway to manage cardiovascular and urological conditions.

• Hypertension: reduces systemic vascular resistance, helping to achieve target blood pressure levels.
• Benign prostatic hyperplasia (BPH): relaxes smooth muscle in the prostate and bladder neck, improving urinary flow and reducing symptoms.
• Cardiovascular risk management: used as part of combination therapy to lower the risk of hypertension‑related complications.

• Doxazosin selectively antagonizes alpha‑1 adrenergic receptors on vascular smooth muscle and in the prostate. By blocking these receptors, it prevents norepinephrine‑induced vasoconstriction, leading to vasodilation and decreased peripheral vascular resistance. In the lower urinary tract, receptor blockade relaxes smooth muscle at the prostate and bladder neck, facilitating urine passage.

Doxazosin may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

• Dizziness: sensation of light‑headedness, especially after standing.
• Headache: mild to moderate intensity.
• Fatigue: general feeling of tiredness.
• Nasal congestion: stuffy or runny nose.
• Peripheral edema: swelling of ankles or feet.
• Nausea: upset stomach.

Serious or Rare Side Effects

• Severe hypotension: marked drop in blood pressure, potentially causing fainting.
• Syncope: sudden loss of consciousness.
• Priapism: prolonged, painful erection requiring urgent care.
• Angioedema: rapid swelling of face, lips, or throat.
• Allergic reaction: rash, itching, or anaphylaxis.
• Liver injury: abnormal liver function tests.

Before initiating therapy with Doxazosin, certain safety considerations should be observed.

• Blood pressure monitoring: check regularly to avoid excessive hypotension.
• Renal function assessment: adjust use in patients with impaired kidney function.
• Hepatic impairment: use cautiously in moderate to severe liver disease.
• Concomitant antihypertensives: evaluate risk of additive blood‑pressure lowering effects.
• Sudden discontinuation: taper dose to prevent rebound hypertension.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Doxazosin can interact with several medicines, influencing its efficacy or safety profile.

Major Interactions (Avoid)

• Other alpha‑1 blockers (e.g., prazosin, terazosin): may cause additive hypotensive effects.
• Potent CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): increase plasma concentrations, raising risk of adverse events.
• Strong antihypertensive combinations (e.g., nitroprusside): can precipitate severe hypotension.

Moderate Interactions (Monitor Closely):\n- Diuretics (e.g., furosemide): may enhance orthostatic hypotension.

• NSAIDs (e.g., ibuprofen): can blunt antihypertensive response.
• CYP3A4 inducers (e.g., rifampicin): may reduce drug exposure.
• Sildenafil or other PDE5 inhibitors: increase risk of symptomatic hypotension.